Get the Stockscreener App
14.16
4.19%
0.57
Pre-market:
13.81
-0.35
-2.47%
Overview
News
Price History
Option Chain
Financials
Why TEVA Down?
Discussions
Forecast
Stock Split
Dividend History
Teva Pharmaceutical Industries Ltd Adr stock is traded at $14.16, with a volume of 28.63M.
It is up +4.19% in the last 24 hours and down -7.81% over the past month.
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
See More
Previous Close:
$13.59
Open:
$13.36
24h Volume:
28.63M
Relative Volume:
2.46
Market Cap:
$16.23B
Revenue:
$16.54B
Net Income/Loss:
$-1.64B
P/E Ratio:
-9.7655
EPS:
-1.45
Net Cash Flow:
$749.00M
1W Performance:
-7.39%
1M Performance:
-7.81%
6M Performance:
-20.14%
1Y Performance:
+1.36%
1-Day Range:
$12.70
$14.33
1-Week Range:
$12.70
$15.54
52-Week Range:
$12.51
$22.80
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Name
Teva Pharmaceutical Industries Ltd Adr
Sector
Phone
972 (3) 914-8213
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Compare TEVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.16 | 16.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ZTS
Zoetis Inc
|
153.55 | 68.76B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.34 | 45.30B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.57B | 14.35B | 1.85B | 0 | 0.4023 |
|
UTHR
United Therapeutics Corp
|
292.78 | 13.15B | 2.76B | 1.11B | 898.10M | 22.77 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-24 | Upgrade | Argus | Hold → Buy |
| Mar-08-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-12-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-23-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Upgrade | Piper Sandler | Underweight → Neutral |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Nov-27-23 | Upgrade | UBS | Neutral → Buy |
| Jul-06-23 | Upgrade | UBS | Sell → Neutral |
| May-25-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-14-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-04-22 | Downgrade | UBS | Neutral → Sell |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Aug-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-14-22 | Resumed | UBS | Neutral |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-04-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Apr-05-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-25-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-27-22 | Downgrade | Argus | Buy → Hold |
| Oct-28-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-25-20 | Initiated | Oppenheimer | Perform |
| Aug-06-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-27-20 | Resumed | Goldman | Neutral |
| Jun-01-20 | Upgrade | SunTrust | Hold → Buy |
| Apr-24-20 | Resumed | Citigroup | Neutral |
| Apr-06-20 | Upgrade | UBS | Neutral → Buy |
| Feb-24-20 | Downgrade | Edward Jones | Hold → Sell |
| Nov-12-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Oct-17-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-07-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-19-19 | Initiated | Wolfe Research | Peer Perform |
| Jul-15-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Jul-05-19 | Upgrade | Argus | Hold → Buy |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Jun-03-19 | Upgrade | Oppenheimer | Perform → Outperform |
| May-30-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| May-28-19 | Downgrade | UBS | Buy → Neutral |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-07-19 | Resumed | UBS | Buy |
View All
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News
Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities - GlobeNewswire Inc.
Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com
What technical indicators reveal about MYGN stock - uspostnews.com
VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com
Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com
The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com
Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar
What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News
Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
How does TEVA’s price to cash per share ratio compare in the market? - US Post News
Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise
Are Clear Secure Inc’shares a good deal? - US Post News
Molina Healthcare Inc (MOH) stock on the rise: An overview - US Post News
Stocktwits teva sales - Texas is Life
Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Has Hesai Group Sponsored ADR (HSAI) Outpaced Other Auto-Tires-Trucks Stocks This Year? - Yahoo Finance
Recent Insider Activity Could Benefit Dover Corp (DOV) - Knox Daily
Analyzing Northern Trust Corp (NTRS) After Recent Trading Activity - Knox Daily
Understanding the Risks of Investing in QuinStreet Inc (QNST) - Knox Daily
why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.71 - The DBT News
fuboTV Inc [FUBO] is 213.49% higher this YTD. Is it still time to buy? - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s stock price in review: A technical analysis - US Post News
Tilray Brands Inc (TLRY)’s stock price range in the last year - US Post News
AGNC Investment Corp (AGNC) stock analysis: A simple moving average approach - US Post News
What is the investor’s view on Nebius Group N.V (NBIS)? - US Post News
U.S. Bancorp (USB) Stock: A Closer Look at the Market Potential - The News Heater
Evaluating the Impact of 0.95 Increase on NIO Inc ADR’s (NIO) Stock - The News Heater
Comerica, Inc [CMA] Officer makes an insider purchase of 1,630 shares worth 0.11 million. - Knox Daily
Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Director MIGNONE ROBERTO sells 286,000 shares of the company – Knox Daily - Knox Daily
Vice President Thomson Andrew Justin Mackenzi sale 4,047 shares of T. Rowe Price Group Inc [TROW] - Knox Daily
SoundHound AI Inc [SOUN] stock for 409,436 USD was sold by MARCUS LAWRENCE - Knox Daily
Investors in cash trouble should check out Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - SETE News
Selling Buzz: Interpublic Group Of Cos., Inc [IPG] SVP, Controller & CAO CARROLL CHRISTOPHER F sells 18,382 shares of the company – Knox Daily - Knox Daily
United Community Banks Inc [UCB] Records 200-Day SMA of $29.14 - Knox Daily
There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News
A better buy-in window may exist right now for Sotera Health Co (SHC) - SETE News
Wall Street analysts’ outlook for Hamilton Lane Inc (HLNE) - SETE News
Insider Selling: MOSLEY WILLIAM D, Seagate Technology Holdings Plc [STX] Chief Executive Officer divested 20,000 shares – Knox Daily - Knox Daily
Confluent Inc [CFLT] stock for 113,437 USD was sold by Phan Kong - Knox Daily
A company insider recently sold 16,932 shares of Kroger Co [KR]. Should You Sale? - Knox Daily
3 Generic Drug Stocks to Watch - Morningstar
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):